Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Personalis Inc
(NQ:
PSNL
)
5.740
-0.190 (-3.20%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Personalis Inc
< Previous
1
2
3
4
5
Next >
Personalis Announces Collaboration with UC San Diego Moores Cancer Center for Clinical Genomic Testing and Research into Composite Biomarkers and Minimal Residual Disease Detection
February 15, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis to Announce Fourth Quarter and Full-Year Financial Results
February 10, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 01, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis Reports Preliminary Fourth Quarter and Full Year 2021 Revenue
January 06, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate in the 24th Annual Needham Virtual Growth Conference
December 28, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis Launches NeXT Personal™, A Tumor-Informed Liquid Biopsy Assay for MRD and Recurrence Detection With Part-Per-Million Sensitivity
December 16, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference
November 18, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis Named to Inc.'s 2021 Best-Led Companies List
November 12, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis to Present New Data at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
November 11, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis Reports Third Quarter 2021 Financial Results
November 04, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis Announces Updates to NeXT Platform™ Incorporating Additional Key Profiling Capabilities for Advancing Oncology Biomarkers
November 02, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis Announces Issuance of US Patents Related to the Exome-Wide NeXT Liquid Biopsy Platform
October 26, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis Publishes New Data Demonstrating Performance and Utility of SHERPA for High-Accuracy Neoantigen Prediction and Cancer Diagnostic Biomarker Development
October 26, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis to Announce Third Quarter Financial Results on November 4, 2021
October 21, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis Expands Leadership Team With Appointment of Robert Bruce, Vice President of Reimbursement
October 13, 2021
From
Personalis, Inc.
Via
Business Wire
Mayo Clinic Collaborates With Personalis Inc. to Expand Cancer Genomic Testing
October 12, 2021
From
Personalis Inc.
Via
Business Wire
Personalis Receives New VA MVP Task Order and Record Quarterly Orders From Oncology Customers; Reconfirms Total Revenue Outlook for 2021 with Further Accelerated Oncology Growth
September 18, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference
August 26, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis Announces Corporate Headquarters Expansion to Accelerate Growth in Laboratory Operations and Research & Development
August 25, 2021
From
Personalis
Via
Business Wire
Personalis Reports Second Quarter 2021 Financial Results
August 04, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate at the 6th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
August 03, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis, Inc. Publishes New Data Demonstrating a Novel Composite Biomarker NEOPS™ for Predicting Response to Cancer Immunotherapy in Late-Stage Melanoma Patients
August 02, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis to Announce Second Quarter Financial Results on August 4, 2021
July 21, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis Announces NeXT Level Biomarkers Symposium
June 22, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis Announces Delivery of the 125,000th Genome to the U.S. Department of Veterans Affairs Million Veteran Program
June 02, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate at the Oppenheimer MedTech, Tools & Diagnostics Summit
May 18, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis, Inc. to Present at Biomarkers Week Online 2021
May 17, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis Reports First Quarter 2021 Financial Results
May 05, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis to Present at the 2021 Bank of America Healthcare Conference
April 29, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis to Report First Quarter 2021 Financial Results on May 5, 2021
April 21, 2021
From
Personalis, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.